Do SGLT2 Inhibitors and GLP-1 Drugs Lower Alzheimer’s Risk in Diabetics?
SGLT2 Inhibitors and GLP-1 Agonists: Do Diabetes Medications Lower Alzheimer’s Risk? Recent studies in diabetes research have begun to highlight the potential neurological benefits of certain diabetes medications, particularly SGLT2…
